Search Medical Centers

Bladder Cancer Treatment in Tel Aviv

Hospitals and medical centers in Tel Aviv, Israel which treat Bladder Cancer patients.
Browse by city:

Assuta Hospital

The new Assuta Hospital was opened in 2009, and claims to be the most modern hospital in the middle east.

Availability:

Bladder Cancer is treated at Assuta Hospital

11 listed oncologists:

view all >

Rabin Medical Center

The Davidoff Center for the research and treatment of cancer is one of the most advanced facilities in the Middle East for the treatment of malignant diseases, delivering medical treatment to approximately 15% of Israel's cancer patients.

Availability:

Bladder Cancer is treated at Rabin Medical Center

6 listed oncologists:

view all >

Prof. Jack Baniel

Deputy Head of the Davidoff Cancer Center's Department of Urology

Prof. M.Shohat

Genetics

Sheba Medical Center

The largest medical centre in Israel and the Middle East, internationally renowned for it's medical excellence. Around 31,000 inpatients are treated annually.

Availability:

Bladder Cancer is treated at Sheba Medical Center

23 listed oncologists:

view all >

Dr. Aderka Dan

Oncology

Dr. Ayalon Shlomo

Surgical Oncology

Herzliya Medical Center

A private hospital located on the shorelines of Herzliya, just off Tel Aviv, offering healthcare services to both local and foreign patients. The hospital is affiliated with over 500 Israeli physicians, many of whom hold high level positions at public hospitals.

Availability:

Bladder Cancer is treated at Herzliya Medical Center

5 listed oncologists:

view all >

Dr. Guttman Live

General Surgery, Oncological Surgery

Assaf Harofeh Medical Center

One of the largest hospitals in Israel with 900 beds and 700 physicians. The hospital serves 1000 medical tourists annually, providing advanced medical care at the highest western standards.

Availability:

Bladder Cancer is treated at Assaf Harofeh Medical Center

Oncology centers in Tel Aviv (Page 1 of 1)

About Bladder Cancer Treatment

This information is intended for general information only and should not be considered as medical advice on the part of Health-Tourism.com. Any decision on medical treatments, after-care or recovery should be done solely upon proper consultation and advice of a qualified physician.


What is bladder cancer?

Bladder cancer has better prognosis if it is detected and treated early. Various treatment options are available but, the choice depends mainly on the stage and grade of the cancer.


What are the treatment options for bladder cancer?

The choice of treatment usually differs in various stages and includes surgery, chemotherapy, radiation therapy and immunotherapy.

  • Surgery: Bladder cancer present in the inner surface of bladder can be removed by cystoscopy called as transurethral resection of bladder tumour (TURBT). The tumor which has grown into the bladder wall needs to be removed by cystectomy in which a part (partial cystectomy) or whole (radical cystectomy) of the bladder is removed.
  • Chemotherapy: Chemotherapy uses strong and powerful drugs to destroy bladder cancer cells and help prevent the recurrence. Mitomycin C is instilled inside the bladder after the TURBT. The commonly used chemotherapy drugs for the treatment of bladder cancer include methotraxate, vinblastine, doxorubicin and cisplatin. Chemotheray helps in treating the bladder cancer that spreads beyond the bladder to other organs or lymph nodes.
  • Radiation therapy: It can be used alone or in combination with chemotherapy. It uses high-dose x-rays or other high-energy rays to destroy cancer cells.
  • Immunotherapy: Immunotherapy causes the body’s own defence mechanism to attack against the cancer cells. Bacilli Calmette-Guerin (BCG) is a substance that stimulates immune system and is used in the bladder cancer. Immunotherapy is used mainly in the early stages of bladder cancer or following cystoscopic removal of cancer to prevent the recurrence of cancer cells.

What is the success rate of bladder cancer treatment?

Superficial bladder cancer recurs in 30%-40% of the cases. Mitomycin C used immediately after TURBT decreases the chances of cancer recurrence within first two years after surgery.

Days admitted : Usually 3- 5 days

Anesthesia : General anesthesia

Risks : Risks are associated with the type of procedures involved: bleeding, infection, pain in surgery, urinary continence problems in total cystectomy, nausea or vomiting, reaction to medicines in chemotherapy, anesthesia related risks

After care : Regular follow up is required to determine the control of bladder cancer or any further spread or recurrence.

Learn more about Bladder Cancer

Browse by country

Copyright © 2008 - 2016 Health-Tourism.com, All Rights Reserved